A mutant DJ-1 gene causes recessive Parkinson's disease, but the molecular mechanism of this process has not been well ...

Tongue coating analysis reveals potential biomarkers for early Parkinson's disease detection, offering a non-invasive and ...

To understand how DJ-1 hydrolyzes cyclic 3-phosphoglyceric anhydride—a highly reactive, toxic cellular metabolite—researchers ...

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...

Acquires a highly selective and brain penetrant NLRP3 inhibitor from Mwyngil Therapeutics Company's lead candidate BT-267, a ...

In a field where treatment options are limited and rapid disease progression remains difficult to manage, Alterity ...

Emerging research positions TUDCA, a bile acid compound, as a promising neuroprotective agent against Alzheimer’s, ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy of Neurology Conference to present findings from his patient survey ...

Dementia with Lewy bodies (DLB), the second most common type of dementia, requires a multifactorial approach to reduce symptoms.

Ambroxol, a common cough medicine used in Europe, demonstrated target engagement in people with Parkinson's disease dementia but did not show an effect on cognition compared with placebo, a year ...

If living near a golf course seems scenic and relaxing, it may also be linked to a higher risk of Parkinson’s disease, according to a surprising new study that comes with some limitations.